NFKB1 and cancer: To validate the induction of NF-κB activity by PRAS40 in cancer cells, we examined p65–DNA-binding activity and mRNA levels of A20 and COX-2, two target genes of NF-κB in cancer cells with normal expression and knocking down of PRAS40.